Rhinoplasty. Other reconstructive surgery
Conditions
Interventions
Intervention 1: Intervention group 1: Tranexamic acid, 10 mg/kg, immediately after anesthesia induction, intravenously. Intervention 2: Intervention group 2: Dexmedetomidine, 1 µg/kg, immediately afte
Prevention
Intervention group 1: Tranexamic acid, 10 mg/kg, immediately after anesthesia induction, intravenously.
Intervention group 2: Dexmedetomidine, 1 µg/kg, immediately after anesthesia induction, intravenously.
Sponsors
Iran University of Medical Sciences, Vice Chancellor for Research
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patient satisfaction; Age between 18-60 years old; ASA class I-II. Exclusion criteria: Patients with liver, kidney, and cardiovascular diseases or diabetes mellitus; Opium addiction; Using benzodiazepines or clonidine; Sensitivity to study drugs; Pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgeon satisfaction. Timepoint: From the onset of surgery to its end. Method of measurement: Based on surgeon opinion as good, moderate, and bad.;Bleeding volume. Timepoint: From the onset of surgery to its end. Method of measurement: The number of used gases.;Blood pressure. Timepoint: From the onset of surgery since 180 minutes later, every 30 minutes. Method of measurement: Sphygmometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgery duration. Timepoint: From the onset of surgery to its end. Method of measurement: Minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira
Berenjian
Outcome results
None listed